Eledon Pharmaceuticals In... (ELDN)
3.99
-0.16 (-3.86%)
At close: Mar 03, 2025, 3:59 PM
3.99
0.00%
After-hours: Mar 03, 2025, 03:59 PM EST
Eledon Pharmaceuticals Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -116.54M | -87.97M | -34.51M | -22.81M | -16.01M | -14.06M | -13.12M | -37.96M | -45.09M | -23.3M | -15.72M | -9.65M |
| Depreciation & Amortization | 374K | 373K | 195K | 183K | 182K | 11K | 22K | 171K | 109K | 21K | 10K | 9K |
| Stock-Based Compensation | 6.54M | 8.15M | 7.9M | 3.17M | 1.31M | 1.54M | 579K | 3M | 2.9M | 2.11M | 238K | 210K |
| Other Working Capital | -2.32M | 287K | -2.29M | -141K | 189K | -476K | -517K | -1.31M | 561K | -556K | 760K | 216K |
| Other Non-Cash Items | 75.01M | 48.65M | 6.15M | 4.83M | 1.87M | 471K | 49K | -2K | -235K | -158K | 238K | 210K |
| Deferred Income Tax | n/a | n/a | -2.35M | -404K | n/a | n/a | n/a | 352K | 72K | n/a | -238K | -210K |
| Change in Working Capital | -4.92M | 2.37M | -152K | -180K | -1.2M | 618K | -2.48M | -2.08M | 1M | 204K | 1K | 97K |
| Operating Cash Flow | -39.53M | -28.42M | -28.91M | -15.21M | -13.86M | -11.89M | -14.94M | -36.52M | -41.24M | -21.12M | -15.48M | -9.33M |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -17K | -565K | -25K | -23K | -8K |
| Acquisitions | n/a | n/a | n/a | 11.04M | n/a | n/a | 23.25M | -2K | n/a | n/a | n/a | n/a |
| Purchase of Investments | -78.29M | n/a | n/a | n/a | n/a | n/a | n/a | -500K | -39.88M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 33M | n/a | n/a | n/a | n/a | n/a | n/a | 36.2M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | 11.04M | n/a | n/a | 8K | 2K | -70K | -150K | -30K | n/a |
| Investing Cash Flow | -45.29M | n/a | n/a | 11.04M | n/a | n/a | 23.26M | 35.68M | -40.51M | -175K | -53K | -8K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.93M | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | -25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | -449K | 100.58M | n/a | 71K | 3.12M | n/a | 513K | -3.13M | 35.59M | 18.78M |
| Financial Cash Flow | 33.02M | n/a | -449K | 109.58M | 9.68M | 7.56M | 7.87M | 37K | 513K | 94.8M | 35.59M | 18.78M |
| Net Cash Flow | -51.8M | -28.42M | -29.36M | 105.4M | -4.18M | -4.33M | 16.19M | -800K | -81.23M | 73.5M | 20.06M | 9.44M |
| Free Cash Flow | -39.53M | -28.42M | -28.91M | -15.21M | -13.86M | -11.89M | -14.94M | -36.54M | -41.8M | -21.15M | -15.5M | -9.34M |